PF-ILD accompanying yearly CT is a questionable disease in the field of infectious respiratory digestive and endocrine disorders. Clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized diagnosis are critical for improving prognosis.
Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation. The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILD accompanying yearly CT requires individualized development, typically including multidimensional management, such as drug therapy, rehabilitation, and regular follow-up.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Treatment requires close monitoring of therapeutic efficacy and adverse reactions, adapting to timely schemes based on disease changes. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the annual PCT with PF-ILD.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.